Philip Russel Taylor

Philip Russel Taylor

Auto-generated profile, based on publicly available information

Philip Russel Taylor

Systems Immunity Research Institute, Division of Infection and Immunity, Cardiff University

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
SGSiamon Gordon
Siamon Gordon
PTPhilip R. Taylor
Philip R. Taylor

18 September 2013 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
LDLuke C Davies
Luke C Davies
SJStephen Jenkins
Stephen Jenkins
JAJudith E Allen
Judith E Allen
PTPhilip R Taylor
Philip R Taylor

1 April 2005 in Annual Review of Immunology
Verified
Journal Article
Closed access
PTP.R. Taylor
P.R. Taylor
LML. Martinez-Pomares
L. Martinez-Pomares
MSM. Stacey
M. Stacey
HLH-H. Lin
H-H. Lin
GBGordon D. Brown
Gordon D. Brown
SGS. Gordon
S. Gordon
▪ Abstract Macrophages express a broad range of plasma membrane receptors that mediate their interactions with natural and altered-self components of the host as well as a range of microorganisms. Recognition is followed by surface changes, uptake, signaling, and altered gene expression, contributing to homeostasis, host defense, innate effector mechanisms, and the induction of acquired immunity. This review covers recent studies of selected families of structurally defined molecules, studies that have improved understanding of ligand discrimination in the absence of opsonins and differential responses by macrophages and related myeloid cells.

10 December 2006 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
PTPhilip R Taylor
Philip R Taylor
STS Vicky Tsoni
S Vicky Tsoni
JWJanet A Willment
Janet A Willment
KDKevin M Dennehy
Kevin M Dennehy
MRMarcela Rosas
Marcela Rosas
GBGordon D. Brown
Gordon D. Brown

29 July 2002 in Journal of Experimental Medicine
Verified
Journal Article
Open access
GBGordon D. Brown
Gordon D. Brown
PTPhilip R Taylor
Philip R Taylor
DRDelyth M Reid
Delyth M Reid
JWJanet A Willment
Janet A Willment
DWDavid L Williams
David L Williams
SGSiamon Gordon
Siamon Gordon
Zymosan is a β-glucan– and mannan-rich particle that is widely used as a cellular activator for examining the numerous responses effected by phagocytes. The macrophage mannose receptor (MR) and complement receptor 3 (CR3) have historically been considered the major macrophage lectins involved in the nonopsonic recognition of these yeast-derived particles. Using specific carbohydrate inhibitors, we show that a β-glucan receptor, but not the MR, is a predominant receptor involved in this process. Furthermore, nonopsonic zymosan binding was unaffected by genetic CD11b deficiency or a blocking monoclonal antibody (mAb) against CR3, demonstrating that CR3 was not the β-glucan receptor mediating this activity. To address the role of the recently described β-glucan receptor, Dectin-1, we generated a novel anti–Dectin-1 mAb, 2A11. Using this mAb, we show here that Dectin-1 was almost exclusively responsible for the β-glucan–dependent, nonopsonic recognition of zymosan by primary macro-phages. These findings define Dectin-1 as the leukocyte β-glucan receptor, first described over 50 years ago, and resolves the long-standing controversy regarding the identity of this important molecule. Furthermore, these results identify Dectin-1 as a new target for examining the immunomodulatory properties of β-glucans for therapeutic drug design.

1 April 2013 in Immunity
Verified
Journal Article
Closed access
YMYuting Ma
Yuting Ma
SASandy Adjemian
Sandy Adjemian
SMStephen R. Mattarollo
Stephen R. Mattarollo
TYTakahiro Yamazaki
Takahiro Yamazaki
LALaetitia Aymeric
Laetitia Aymeric
Guido KroemerGuido Kroemer
Guido Kroemer